Earnings Call · Q2 FY2025·2025-08-06

Q2 25EPS +5.62%·Rev n/aQ1 25EPS +100.00%*·Rev n/aQ4 24EPS +34.38%·Rev n/aQ3 24EPS +21.84%·Rev n/a⚠ consensus missing

ARVINAS, INC. ARVN

Jeff Boyle — Vice President of Investor Relations

John G. Houston — Chief Executive Officer

Noah Berkowitz — Chief Medical Officer

Angela M. Cacace — Senior Vice President, Research

Andrew R. Saik — Chief Financial Officer

−15.5%1d on move date−16.3% vs SPY3d−17.3%5d−10.8%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ARVN calls or request research access.

More ARVN calls Browse calls Request research access